http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0696195-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 |
filingDate | 1994-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b1d641985e1d492f54e9e48e97fb192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43da9379865e7dc8f69e78dbe96ae7c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2a3fa93b3850b45cc6eed46202b388c |
publicationDate | 1996-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0696195-A1 |
titleOfInvention | Use of sabeluzole in chronic neurodegenerative diseases |
abstract | The present invention is concerned with the use of sabeluzole for the manufacture of a medicament for the treatment of patients suffering from chronic neuro-degenerative diseases such as dementia of the Alzheimer type (DAT) or Alzheimer's disease, amyotrophic lateral sclerosis (ALS), dementia associated with Parkinson's disease and related diseases which are characterized by progressive dementia. |
priorityDate | 1993-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 51.